Poor diagnostic results can lead to improper diagnoses, delays in treatment or other consequences. To set patients on the right clinical path, a timely and accurate diagnosis is crucial. Our BD® Diagnostic Accuracy and Efficiency Program can help you optimize the process from specimen collection through the delivery of lab results, and recommends BD solutions to help you minimize errors and complications like specimen contamination and retesting.

With access to high-quality results in less time, clinicians can feel confident that accurate information is informing a more optimal diagnosis and treatment plan. Discover how the right results can lead to a shorter length of stay and a better experience for everyone.

Learn more about how timely and accurate results impact patient care

Thank you for your interest.

12 million adults

are affected by outpatient diagnostic errors annually in the United States.6

Up to 75% of lab diagnostic

errors occur in the preanalytical phase.7, 8

30–50% of all the antibiotics

prescribed for people are not needed or are not optimally effective as prescribed. 9, 10, 11

Proper cleaning and decontamination of a patient's skin, such as before providing a urine sample or drawing a blood sample, helps reduce contamination rates.

44% of ER and inpatients were prescribed inappropriate antibiotics due to contaminated urine cultures.1

The specimen collection method can impact specimen integrity.

56% of blood collections are from patients with diagnoses associated with difficult venous access2 (e.g., cancer, chronic cardiovascular disease, chronic kidney disease, diabetes, blood disorders/anemias and obesity).

The transport method can impact turnaround time and specimen quality, resulting in unnecessary recollects or inappropriate patient therapy.

Bacteria doubles in an unpreserved urine specimen every 20 minutes at room temperature.3

The testing method, timing and process can impact the time to reporting.

A 10-min reduction in lab result turnaround time = 6.7 min reduction in ED length of stay.4

Time to reporting of results can have an impact on clinical decisions and therefore patient treatment.

Many physicians surveyed believed that laboratory turnaround time caused delayed ED treatment more than 50% of the time and increased ED length of stay more than 50% of the time.5


  • Reducing lab turnaround time and emergency department length of stay
  • Minimizing specimen contamination rate
  • Improving patient and healthcare worker experience
  • Maximizing diagnostic accuracy


  • Reviewing current practices and policies through clinical assessments from specimen collection through delivery of lab results
  • Providing recommendations based on a baseline assessment of how BD solutions can address identified gaps and improve performance in people, processes and technologies
  • Helping clinicians adhere to best practice through training and education

1. Klausing BT, Tillman SD, Wright PW, Talbot TR. The influence of contaminated urine cultures in inpatient and emergency department settings. Am J Infect Control. 2016;44(10):1166-1167. doi: 10.1016/j.ajic.2016.03.055.
2. Data on File: REF-1882 BD Venipuncture Burden Insurance Data, U.S. 2012.
3. Bryan C. Infectious disease, chapter 7: urinary tract infections. In: Microbiology and Immunology On-line. Columbia, SC: University of South Carolina School of Medicine; 2017. Accessed on April 17, 2017 at http://microbiologybook.org/Infectious%20Disease/Urinary%20Tract%20Infections.htm.
4. Mitra D, Erdal E, Khangulov V, Tuttle R. Association between laboratory test turnaround time and emergency department length of stay: a retrospective US electronic health database analysis. Poster session presented at: American Association for Clinical Chemistry 2015 Annual Meeting and Clinical Lab Expo; July 26-30, 2015; Atlanta, GA.
5. Steindel SJ, Howanitz PJ. Physician satisfaction and emergency department laboratory test turnaround time. Arch Pathol Lab Med. 2001;125(7):863-871.
6. Singh H, Meyer AN, Thomas EJ. The frequency of diagnostic errors in outpatient care: estimations from three large observational studies involving US adult populations. BMJ Qual Saf. 2014;23(9):727-731. doi: 10.1136/bmjqs-2013-002627.
7. Lippi G, Chance JJ, Church S, et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med. 2011;49(7):1113-1126. doi:10.1515/CCLM.2011.600.
8. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem. 2002;48(5):691-698.
9. Centers for Disease Control and Prevention (CDC). Antibiotic Resistance Threats in the United States, 2013. Available at https://www.cdc.gov/drugresistance/threat-report-2013. Published September 16, 2013. Accessed September 18, 2018.
10. Centers for Disease Control and Prevention (CDC). 1 in 3 antibiotic prescriptions unnecessary. Available at https://www.cdc.gov/media/releases/2016/p0503-unnecessary-prescriptions.html. Last reviewed January 1, 2016. Accessed September 18, 2018.
11. Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA. 2016;315(17):1864-1873.